Sodium-Glucose Cotransporter 2 Inhibitors Improve Chronic Diabetic Macular Edema

Figure 3

Case 3. Optical coherence tomographic images and fundus photographs showing the central macular thickness (CRT) pre (A, B) and at 10 days (C, D), 1 month (M) (E, F), 3 M (G, H), and 6 M (I, J) after commencing the oral sodium-glucose cotransporter 2 inhibitor (SGLT2i).